Hepatitis C Treatment Market to Register Stellar Compound Annual Growth Rate Th

Posted by Mackullam David on May 13th, 2019

"Demand for Hepatitis C Treatment Expected to Remain High in North America during 2018-2026

According to a recent study conducted by TMR, the global market for hepatitis C treatment is expected to expand at a CAGR of over XX% during the forecast period (2018-2026). By the end of 2018, market is anticipated to stand at US$ XX and is estimated to surpass US$XX Billion by 2026.

Factors such as higher per capita healthcare expenditure worldwide and growing prevalence of hepatitis C infections in countries such as U.S. and Canada is expected to drive the global market for global hepatitis C treatment during the forecast period. Moreover, increasing awareness campaigns by private NGPOs and encouraging government initiatives to limit infection is also supporting the market growth. On the other hand, expensive drugs for hepatitis C treatment and lack of awareness about hepatitis C infection amongst the people in developing regions across the globe may inhibit the growth of the market during the forecast period.

Get More Information About Hepatitis C Treatment Market- https://www.trendsmarketresearch.com/report/sample/3728

On the basis of drugs, the global market for hepatitis C treatment has been segmented into HCV NS5A inhibitors, HCV protease inhibitors, interferon & antiviral, HCV polymerase inhibitors, and combination therapy. Amongst these, combination therapy is expected to be the largest, accounting for the highest share of the market. The segment is expected to expand at a CAGR of over XX% during 2018-2026.

On the basis distribution channel, the market has been segmented into online pharmacies, hospital pharmacies and retail pharmacies. Hospital pharmacy is expected to be the most dominant segment during the forecast period. By 2026, the segment is anticipated to account for over 43% share of the market in terms of revenue. Due to increasing occurrence of hospitalization and improved services and accessibility, demand for the segment is expected to grow higher in the near future.

On the other hand, the online pharmacies segment is anticipated to witness the highest CAGR over the forecast period. The growth of the segment is due to ample stock of hepatitis C treatment drugs with added discount offered by online drug pharmacies.

On the basis of region, North America is expected to be the leading market for hepatitis C treatment, estimated to account for 45% share by the end of 2016. Whereas, the market in Asia Pacific is anticipated to expand at an overwhelming CAGR of over XX%. By 2018, Europe is estimated to contribute over 19% share to the global market for hepatitis C treatment. The market in Latin America is expected to witness a sound growth, which was estimated at US$ XX Million in 2018 and is expected to surpass US$ XX by 2026 year end. In 2015, the market in the Middle East and Africa (MEA) region stood at US$ XX Million and is anticipated to cross US$ XXMillion by the end of 2018.

Vendor News

Key participants operating in the global market for hepatitis C treatment include F Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc., AbbVie Inc., and Kadmon Holdings, Inc. Most of these companies are actively focusing on partnering with healthcare solutions and service providers in order to offer better patient treatment and enhance operational efficiency.

Report Description: https://www.trendsmarketresearch.com/report/hepatitis-c-treatment-market

View More: HEALTHCARE, PHARMACEUTICALS & MEDICAL DEVICES

About Us:

Trends Market Research is one of the leading digital services provider and a result-oriented company based in U.K.. We are a team of enthusiastic-driven individuals with top notch skills in SEO , Market research. Trends Market Research is a one stop shop to all your business needs. We help you thrive and succeed. We provide research solution.

Our digital and enterprise research assurance solutions are ideal for Automotive & Transportation, Electronics & Semiconductor, Chemicals & Materials, Healthcare, Pharmaceuticals & Medical Devices, Food & Beverage and Industrial Automation as well as all type of other leading industries verticals . We offer a vast line of in-depth study of industry trends including customized & client oriented specific requirement.

Contact Us

One Vincent Square
Westminster, London SW1P 2PN
United Kingdom

Also See: Hepatitis C, C Treatment, Us Xx, Global Market, Treatment, Market, Hepatitis
Link To Directory
Top Searches - Trending Searches - New Articles - Top Articles - Trending Articles - Featured Articles - Top Members

Copyright 2019 Uberant.com
560,118 total articles and counting.